Skip to main content

GILD Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Gilead Sciences Inc. News

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Pfizer Used AI to Design Paxlovid. Is Schrondinger Next?

Biotech may be one of the biggest beneficiaries of artificial intelligence and machine learning.

Cramer's Mad Money Recap 3/18: Nike, Nvidia, Adobe

Game plan for the week ahead with earnings from Nike, Adobe, KB Home and a keynote from Nvidia's CEO.

Cramer's Mad Money Recap 2/4: Take-Two Interactive, Disney, Twitter

Earnings from Take-Two Interactive, Disney and Twitter highlight Jim Cramer's game plan for next week.

Gilead Sciences Sues to Block Sellers of Counterfeit HIV Meds

Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.

Breaking News

Disney Mobile Game Opens Up a New Universe

Familiar Disney characters populate an alternate reality in new interactive game.

Birth Control Stocks May Benefit From the Reversal of Roe v. Wade

The historic Supreme Court decision may force women to make different choices.

Barstool's Portnoy Takes a Surprising Stand on a Key Political Issue

The outspoken Republican with a platform voices his opinion on the state of democracy moving to the right.

McDonald's Brings Back a Classic Menu Item (with a Catch)

You never know what the fast-food chain might bring back or create a new version of.